首页> 外文OA文献 >Effect of Intensive Statin Therapy on Regression of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome A Multicenter Randomized Trial Evaluated by Volumetric Intravascular Ultrasound Using Pitavastatin Versus Atorvastatin (JAPAN-ACS Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Study)

【2h】

Effect of Intensive Statin Therapy on Regression of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome A Multicenter Randomized Trial Evaluated by Volumetric Intravascular Ultrasound Using Pitavastatin Versus Atorvastatin (JAPAN-ACS Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Study)

机译：强化他汀类药物治疗对急性冠脉综合征患者冠状动脉粥样硬化的消退效果的评价：皮塔伐他汀与阿托伐他汀对比血管内超声对多中心随机试验进行评估（JAPAN-ACS 日本冠状动脉综合征中匹伐他汀和阿托伐他汀的日本评估）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Hiro Takafumi; Kimura Takeshi; Morimoto Takeshi; Miyauchi Katsumi; Nakagawa Yoshihisa; Yamagishi Masakazu; Ozaki Yukio; Kimura Kazuo; Saito Satoshi; Yamaguchi Tetsu; Daida Hiroyuki; Matsuzaki Masunori;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS (Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome) study). [J] . Hiro T, Kimura T, Morimoto T Journal of the American College of Cardiology . 2009,第4期

机译：强化他汀类药物治疗对急性冠状动脉综合征患者冠状动脉粥样硬化的消退的影响：一项使用匹伐他汀与阿托伐他汀进行容积血管内超声评估的多中心随机试验（JAPAN-ACS（日本对急性冠状动脉综合征中匹伐他汀和阿托伐他汀的日本评估）研究）。
2. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: Serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial [J] . HibiK., KimuraT., KimuraK., Atherosclerosis . 2011,第2期

机译：他汀类药物强化治疗后急性冠脉综合征的临床上明显的多血管疾病和冠状动脉粥样硬化的消退：日本评估匹伐他汀和阿托伐他汀在急性冠脉综合征中的连续血管内超声（JAPAN-ACS）试验
3. Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome--serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial). [J] . Hiro T, Kimura T, Morimoto T, Circulation journal . 2010,第6期

机译：糖尿病是他汀类药物治疗急性冠状动脉综合症患者期间冠状动脉斑块消退的主要阴性决定因素-日本Pitavastatin和Atorvastatin急性冠脉综合征试验（JAPAN-ACS试验）中日本对血清血管内超声的观察。
4. Smoking-Related Low HDL-C Level and Regression of Coronary Atherosclerosis during Statin Therapy (from the JAPAN-ACS study) [C] . Ando J., Hirata Y., Nagai R., World Congress on Heart Disese-International Academy of Cardiology Annual Scientific Session 2010 . 2010

机译：吸烟相关的低HDL-C水平和冠状动脉粥样硬化期间的冠状动脉粥样硬化（来自日本ACS研究）
5. Clarifying the Optimal Management Strategy for Patients with Possible Acute Coronary Syndrome with Intermediate Stenosis and High-Risk Plaque Morphology on Coronary Computed Tomographic Angiography [D] . Dwyer, Stephanie M. 2019

机译：明确可能的急性冠脉综合征合并中度狭窄和高风险斑块形态的冠状动脉计算机断层扫描血管造影的最佳管理策略
6. Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF): Rationale and design of the prospective randomized parallel-group open-label blinded-endpoint superiority multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stenting [O] . Lisa Riesinger, Claudia Strobl, David M. Leistner, 2021

机译：Apixaban与苯procoumon：口服抗凝加抗血小板治疗急性冠状动脉综合征和心房颤动的患者（方法-ACS-AF）：理论和设计前瞻性随机平行开放标签盲 - 终点优势多中心试验对心房颤动患者的三重治疗与双重治疗和急性冠状动脉综合征接受冠状动脉抵抗
7. Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial). [O] . Hiro, Takafumi, Kimura, Takeshi, Morimoto, Takeshi, 2010

机译：糖尿病是急性冠脉综合征患者他汀类药物治疗期间冠状动脉斑块消退的主要决定因素：来自日本的匹伐他汀和阿托伐他汀评估在急性冠状动脉综合征试验中的连续血管内超声观察（JapaN-aCs试验）。

著录项

相似文献

相关主题

期刊订阅